Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope.
Amino Acid Sequence
Binding Sites
CD4-Positive T-Lymphocytes
/ cytology
Colorectal Neoplasms
/ metabolism
Crystallography, X-Ray
Epitopes
/ chemistry
HLA-DR1 Antigen
/ chemistry
Humans
Membrane Glycoproteins
/ chemistry
Molecular Dynamics Simulation
Peptides
/ chemistry
Protein Binding
Protein Structure, Secondary
Protein Structure, Tertiary
T-cell biology
antigen presentation
antigen recognition
crystallography
molecular dynamics
peptide flanking residues
structure-function
tumor immunology
Journal
The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R
Informations de publication
Date de publication:
27 12 2019
27 12 2019
Historique:
received:
09
06
2019
revised:
18
09
2019
pubmed:
18
10
2019
medline:
23
6
2020
entrez:
18
10
2019
Statut:
ppublish
Résumé
CD4
Identifiants
pubmed: 31619516
pii: S0021-9258(20)30040-5
doi: 10.1074/jbc.RA119.009437
pmc: PMC6937582
doi:
Substances chimiques
Epitopes
0
HLA-DR1 Antigen
0
Membrane Glycoproteins
0
Peptides
0
trophoblastic glycoprotein 5T4, human
0
Banques de données
PDB
['4CNM', '6HBY']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
20246-20258Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Informations de copyright
© 2019 MacLachlan et al.
Références
Annu Rev Immunol. 2015;33:169-200
pubmed: 25493333
Br J Cancer. 1990 Jan;61(1):89-95
pubmed: 2404511
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13279-84
pubmed: 15331779
Nature. 1996 Jun 13;381(6583):616-20
pubmed: 8637599
J Clin Invest. 2010 May;120(5):1578-90
pubmed: 20407212
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W537-41
pubmed: 22570416
Immunity. 1997 Sep;7(3):387-99
pubmed: 9324359
J Immunol Methods. 2016 Mar;430:43-50
pubmed: 26826277
Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
pubmed: 15299374
J Comput Chem. 2005 Dec;26(16):1668-88
pubmed: 16200636
Eur J Immunol. 2013 Sep;43(9):2273-82
pubmed: 23719902
J Exp Med. 1994 Jun 1;179(6):1945-56
pubmed: 7515103
J Immunol. 2002 Jul 15;169(2):739-49
pubmed: 12097376
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67
pubmed: 21460454
J Immunol. 2015 Dec 15;195(12):5827-36
pubmed: 26553072
Cancer Immunol Res. 2013 Dec;1(6):null
pubmed: 24409450
Sci Rep. 2012;2:629
pubmed: 22953050
J Biol Chem. 2018 May 18;293(20):7538-7548
pubmed: 29599287
J Immunol. 2015 Jan 1;194(1):463-74
pubmed: 25452566
Immunogenetics. 1985;21(3):235-46
pubmed: 3872841
Protein Sci. 1994 Dec;3(12):2207-16
pubmed: 7756980
J Immunol Methods. 2009 Jan 1;340(1):11-24
pubmed: 18929568
Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1227-31
pubmed: 8433983
Immunome Res. 2008 Nov 26;4:6
pubmed: 19036163
J Chem Theory Comput. 2013 Sep 10;9(9):3878-88
pubmed: 26592383
Immunity. 2005 Mar;22(3):371-83
pubmed: 15780993
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95
pubmed: 26583988
J Immunol. 2001 Jun 1;166(11):6720-7
pubmed: 11359828
Methods Mol Biol. 2015;1266:171-84
pubmed: 25560075
Annu Rev Immunol. 1997;15:821-50
pubmed: 9143708
Eur J Immunol. 2002 Sep;32(9):2510-20
pubmed: 12207335
Immunology. 2018 Jul;154(3):394-406
pubmed: 29315598
Immunology. 2015 Sep;146(1):11-22
pubmed: 26076649
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Acta Crystallogr D Biol Crystallogr. 2007 Jan;63(Pt 1):32-41
pubmed: 17164524
Nat Commun. 2012 Feb 07;3:665
pubmed: 22314361
Structure. 2014 Apr 8;22(4):612-20
pubmed: 24582434
BMC Bioinformatics. 2009 Feb 11;10:60
pubmed: 19210785
Cancer Immunol Immunother. 2019 Feb;68(2):247-256
pubmed: 30406375
Br J Cancer. 1992 Nov;66(5):867-9
pubmed: 1419629
J Immunol. 2002 Nov 1;169(9):5089-97
pubmed: 12391225
Oncotarget. 2017 Jul 18;8(29):47474-47489
pubmed: 28537896
Protein Expr Purif. 1999 Feb;15(1):105-14
pubmed: 10024477
J Immunol. 1998 Jul 15;161(2):850-8
pubmed: 9670963
Front Immunol. 2013 Jul 01;4:172
pubmed: 23847615
JAMA Oncol. 2017 Oct 12;3(10):e172579
pubmed: 28880972